Drug Trial Radar · NCT07406633
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
Last checked: Nov 19, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
46
Planned (sponsor's estimate)
Start
Jun 23, 2026
Primary completion
Oct 2027
Study completion Oct 2028
Sponsor
- Lead sponsor
- Kumquat Biosciences Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will test an experimental drug called KQB198 in combination with imatinib. The goal is to determine if this combination is safe and tolerable and assess how effective the combination is at treating GIST. Imatinib has been approved by the FDA for the treatment of different types of cancer including GIST.
Conditions
- GIST - Gastrointestinal Stromal Tumor
- GIST
- GIST Metastatic Cancer
- Gastro Intestinal Stromal Tumour
- Gastrointestinal Tumors
Interventions
KQB198Drug
Oral KQB198
Imatinib (Gleevec)Drug
Oral Imatinib
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective response rate (ORR)Time frame: 30 months
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
USC Norris Comprehensive Cancer Center
Los Angeles, California · Recruiting
Mayo Clinic - Jacksonville
Jacksonville, Florida · Recruiting
Sylvester Comprehensive Cancer Center
Miami, Florida · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
University of Chicago Medical Center
Chicago, Illinois · Recruiting
University of Iowa Health Care
Iowa City, Iowa · Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts · Recruiting
University of Michigan Hospitals
Ann Arbor, Michigan · Recruiting
Mayo Clinic - Rochester
Rochester, Minnesota · Recruiting
Northwell Health/R.J. Zuckerberg Cancer Center
Lake Success, New York · Recruiting
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina · Recruiting
Cleveland Clinic
Cleveland, Ohio · Recruiting
Oregon Health & Science University
Portland, Oregon · Recruiting
Fox Chase Cancer Center
Philadelphia, Pennsylvania · Recruiting
UT MD Anderson Cancer Center
Houston, Texas · Recruiting
Huntsman Cancer Institute
Salt Lake City, Utah · Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.